A new comprehensive hereditary cancer solution offers genetic counseling and multigene panels to enhance early detection of disease's like brain cancer.

Mice with identical genetics and environmental exposures display different cancer risk profiles based on distinct epigenetic ...

A study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.

Fact checked by Nick Blackmer Meet the Expert Marla Anderson, MD, FACS, is a board-certified surgeon specializing in breast ...

Mutations in BRCA2—a gene known to repair damaged DNA and suppress tumor formation—can predict an individual's predisposition ...